BIIB

NASDAQ · Biotechnology

Biogen Inc

S&P 500 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$207.94

+1.66 (+0.80%)

As of Aug 9, 9:36 PM ET ·

Day Range $204.16 — $208.31

52W Range $127.00 — $219.72

Performance

1D —

1W —

1M —

3M —

6M +8.76%

1Y +62.45%

YTD +16.94%

Open$207.38

Previous Close$206.28

Day High$208.31

Day Low$204.16

52W High$219.72

52W Low$127.00

Volume—

Avg Volume1.15M

Market Cap30.26B

P/E Ratio36.26

EPS$5.65

SectorBiotechnology

Technical Indicators

Full analysis →

SMA 50 $179.51 Above

SMA 200 $150.33 Above

RSI (14) 64.3 Neutral

Trend Golden Cross Bullish

Analyst Ratings

Buy

43 analysts

29 Buy 13 Hold 1 Sell

Price Target -56.0% upside

Current
$207.94

Target
$91.45

$57.23 $91.45 avg $114.90

Key Financials

	FY 2026	FY 2025	FY 2024
Revenue	9.79B	9.88B	3.09B
Net Income	1.28B	1.16B	745.08M
Profit Margin	13.1%	12.4%	24.1%
EBITDA	2.21B	2.12B	1.15B
Free Cash Flow	—	—	775.19M
Rev Growth	-0.9%	-0.9%	+20.7%
Debt/Equity	0.34	0.34	1.02

Biotechnology Peers

Symbol	Name	Price	Change	P/E	Mkt Cap
ABBV	Abbvie Inc	$246.04	+0.89%	118.6	430.95B
AMGN	Amgen Inc	$410.95	+1.51%	25.1	219.39B
GILD	Gilead Sciences Inc	$133.21	+1.80%	—	165.85B
VRTX	Vertex Pharmaceuticals Inc	$496.07	+2.49%	28.3	124.51B
REGN	Regeneron Pharmaceuticals	$784.36	+1.59%	18.4	79.53B
ALNY	Alnylam Pharmaceuticals Inc	$219.20	+1.43%	35.2	28.41B